Oakes Gregory 4
4 · Landos Biopharma, Inc. · Filed Mar 2, 2023
Insider Transaction Report
Form 4
Oakes Gregory
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-28+475,300→ 475,300 totalExercise: $0.37Exp: 2033-02-27→ Common Stock (475,300 underlying)
Footnotes (1)
- [F1]1/4th of the shares initially subject to the option shall vest on the one (1) year anniversary of the date of grant (such anniversary being the "Anniversary Date") and 1/48th of the shares initially subject to the option shall vest on each monthly anniversary of the Anniversary Date thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.